Breaking AI & Tech News Analyzed

Former world heavyweight champion Tyson Fury has weighed in considerably lighter than his previous fight in 2024, but still carries a few pounds more than his opponent, Russian Arslanbek Makhmudov. Fury registered 267.9 pounds in his underwear during Friday's weigh-in, while Makhmudov stepped up at 264.9 pounds.Fury's weight is a decrease from the 281 pounds he recorded for his rematch with world champion Oleksandr Usyk in December 2024 and 262 pounds against the Ukrainian in May that year. The 37-year-old Briton stated he still had 'a bit left in the tank' as he came out of retirement for the fifth time.'After another four or five retirements, I should be good,' Fury said. 'My priority is to beat this fella, I've got loads of Easter eggs in the fridge ready for me. Whoever has these belts, I want them back.'Fury emphasized his commitment to making a statement, saying he came in 'nice and light and lean' for the fight. He has spent 16 weeks training in Thailand and has promised fans a knockout win at the Tottenham Hotspur Stadium on Saturday night.'I'll knock his head right off his two shoulders,' Fury told reporters on Thursday. 'I'll be like the gamecock on top of Tottenham Hotspur Stadium, and he'll be like the knocked-out man sparked out on the floor.'The bout against Makhmudov will be broadcast exclusively on Netflix, highlighting Fury's continued commercial appeal even after a 16-month absence from the ring. Fury boasted about his financial draw, saying, 'I'm the money man. When you mention Tyson Fury in heavyweight boxing, you know you're getting paid.'

Egypt and Al-Ahly goalkeeper Mohamed El-Shenawy has been banned for four games and fined 50,000 Egyptian pounds ($942) for assaulting a referee during a recent match.The incident occurred after Al-Ahly's appeal for a penalty was denied in a 1-1 draw with Ceramica Cleopatra. El-Shenawy, who was on the bench, was incensed and struck the referee on the head.The Egyptian Pro League announced the ban, which will sideline El-Shenawy until the final week of the league playoffs. This is significant as El-Shenawy is expected to be Egypt's starting goalkeeper at the upcoming World Cup in North America.Al-Ahly currently sits third in the league with 41 points, five points behind leaders Zamalek.

The chief executive of the British Horseracing Authority (BHA), Brant Dunshea, announced that the sport is prepared to consider more direct‑action protests as it confronts the government’s proposal to introduce affordability checks for punters. Last September’s one‑day strike, which forced the cancellation of four meetings, proved decisive: it helped the government abandon a planned increase in betting tax from 15% to 21%, a rise the BHA estimated would have cost the industry £330 million. Following the “Axe the Racing Tax” campaign, the BHA is now urging the government to rethink the affordability checks that could require up to 120,000 regular gamblers to provide personal documentation, according to the Betting and Gaming Council. Independent modelling by EY suggests that as many as 44,000 bettors might migrate to black‑market operators, eroding the industry’s betting turnover by tens of millions of pounds. Betting turnover has already fallen by £2 billion since 2021. The Gambling Commission is slated to decide on the checks next month, while more than 400 racing figures – including trainers and MPs – have signed an open letter to Culture Secretary Lisa Nandy demanding intervention. “Our campaign will continue, and direct action is part of our broader strategy, though we will not discuss specifics publicly,” Dunshea said. He highlighted the power of collective action, noting that the industry’s cultural and economic significance was recognised in the government’s recent budget announcement. Recent pilot schemes, involving three credit‑reference agencies, produced inconsistent outcomes for the same individuals, raising concerns that the checks could push more punters toward illegal markets. Data from Yield Sec shows that the share of the UK gambling market held by black‑market operators surged from 0.43% in 2020 to 9% last year, with £379 million wagered on unlicensed platforms that do not contribute to the exchequer. Dunshea stressed that any affordability measure must be truly frictionless. “Consumers are price‑sensitive and protective of their personal data; any intervention that feels invasive will drive them elsewhere,” he warned. Amid the upcoming Grand National at Aintree, Dunshea expressed surprise at recent comments from the RSPCA regarding horse deaths at Cheltenham, reaffirming the BHA’s commitment to a collaborative relationship with the animal‑welfare charity. He noted that over the past 25 years, the industry has invested £60 million in equine welfare, reducing fatality rates to 0.22% of runners, and emphasized that the BHA will continue to work constructively with the RSPCA despite recent tensions.

British computer scientist Adam Back has vehemently denied claims that he is the elusive creator of Bitcoin, known as Satoshi Nakamoto. A recent report in the New York Times had suggested that Back was Nakamoto, but he quickly took to social media to refute the claims. In a thread on X, Back stated, 'I also don’t know who satoshi is, and I think it is good for bitcoin that this is the case, as it helps bitcoin be viewed [as] a new asset class, the mathematically scarce digital commodity.' This denial comes after a years-long effort to unmask Nakamoto, the mysterious author of the bitcoin white paper which laid the theoretical foundations for modern digital currencies. The speculation surrounding Nakamoto's identity has been ongoing for years, with previous attempts pointing to Nick Szabo, Hal Finney, and an 'unknown Australian genius' who was later revealed to be a fraud. The latest trail led to Back, a London-born computer scientist and entrepreneur, who was a member of an online anarchist cryptography community called the cypherpunks in the early 1990s. Journalist John Carreyrou claimed to have found similarities between Back and Nakamoto by analyzing decades of old internet postings and shared niche interests. However, Back attributed the similarities to 'a combination of coincidence and similar phrases from people with similar experience and interests.' Not everyone is convinced by Back's denial, with some speculating that he may still be Nakamoto. Stephen Murdoch, a professor of computer science at University College London, noted that while there are indications that it could be Back, 'there’s no smoking gun.' Meanwhile, Dr. Jacky Mallett, an assistant professor of computer science at Reykjavík University, suggested that Satoshi was 'almost certainly more than one person,' citing updates to the bitcoin code that suggest multiple contributors. Back is the owner of a bitcoin treasury firm that is merging with a publicly traded company. If he were indeed Nakamoto and the owner of 1.1m coins worth tens of billions of pounds, he would have to disclose this to the Securities and Exchange Commission, as it could materially affect the bitcoin market.

JP Morgan Chase has secured approval from London City Airport to build one of Europe's tallest office towers in the east of the capital. The planned £3bn tower, set to be the tallest in the Canary Wharf financial district, will serve as JP Morgan's new UK headquarters.The two sides have agreed that the tower could be 265 meters tall, approximately 30 meters taller than One Canada Square, currently the tallest building in Canary Wharf. The new building will span 279,000 sq meters (3 million sq ft) and house more than half of JP Morgan's 23,000 UK staff.Any new developments within 10km of the airport are considered to be within its 'area of interest', requiring consultation with airport officials to ensure new buildings do not interfere with aircraft movements. Following the conclusion of talks with City airport, JP Morgan is finalizing the tower designs and will soon apply for planning permission.The project is expected to add almost £10bn to the UK economy over six years and create about 7,800 construction-related jobs. Questions are being raised about the financial inducements JP Morgan has sought from the UK government, including a discount on business rates, despite the bank's $57bn (£43bn) net income in 2025.The Treasury has proposed a discount on rates of 'up to 100%' over 'a period of years', potentially representing a saving of hundreds of millions of pounds. The site would generate up to £1.6bn in rates over 25 years if there were no discount.

The peptide-testing industry has seen a significant surge in demand, with laboratories testing thousands of unregulated substances claiming to support weight-loss and wellness. This growth is largely driven by the injectable peptide craze, with experts warning about the lack of reliable safety data and quality control.Peptides are short chains of amino acids, which can be found naturally in the body or made synthetically in laboratories. They include active ingredients in prescription weight-loss drugs, such as Wegovy, as well as experimental compounds pushed online by the booming biohacking and anti-ageing industries.Laboratories, such as Finnrick in Texas, have reported a substantial increase in testing requests, with around 60,000 samples processed annually, including roughly 2,000 orders from the UK since 2024. About a third of the products analysed failed basic quality checks, with issues including incorrect identity, purity, and quantity.Experts, including Dr. Luke Turnock and Peter Magic, have highlighted the risks associated with these unregulated substances, including potential long-term harms such as increased cancer risk and damage to organs. The large profit margins have also drawn nefarious actors into the supply chain.The UK is a significant market for peptides, with 2,000 testing orders since 2024, tied with Canada for third place globally. The Royal Pharmaceutical Society's Prof Amira Guirguis emphasized the need for oversight, traceability, and quality assurance in the peptide market.

The UK government's new employment rights watchdog, the Fair Work Agency (FWA), is set to launch on Tuesday, but its priorities have already faced criticism from worker advocates. The agency, a cornerstone of Labour's Employment Rights Act, will bring together several existing labour enforcement bodies and focus on policing the minimum wage, holiday pay, and modern slavery. However, the government's priorities for the FWA's first year have been criticized for focusing on reducing regulatory burdens on businesses, rather than taking a more robust approach to protecting workers' rights. The priorities, listed by Matthew Taylor, the incoming chair of the FWA, include 'thought leadership' and 'reducing regulatory burdens'. Worker advocates argue that this approach risks turning the agency into 'a dead duck' before it even begins. Sharon Graham, the general secretary of Unite, which represents over 1 million workers, said that the priorities showed the agency was 'in danger of being a dead duck before it even begins'. She added that the government needs to urgently ensure that the FWA focuses on bringing rogue bosses to heel, rather than seeking ways to allow dodgy companies to continue bad behaviour. The UK has among the fewest labour inspectors per worker within Organisation for Economic Co-operation and Development countries, with different estimates putting the scale of unpaid wages in the billions of pounds. This means employers face 'no credible threat of inspection, investigation or enforcement', according to Prof David Whyte of Queen Mary University. A report to be published on Monday by the Institute of Employment Rights will recommend adequate funding, unannounced inspections, and prosecutions for wrongdoing. The government has yet to announce the budget it will allocate to the FWA. A government spokesperson said: 'The new Fair Work Agency will end the current fragmented system of enforcing employment rights, making it easier for workers and victims of exploitation to get the rights they're entitled to. The agency will take tough action against businesses that deliberately flout the law while supporting employers who want to do the right thing and strengthen workers' rights.'

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The prospect of a historic quadruple for Arsenal has evaporated. After a Carabao Cup final loss and a humbling defeat to second‑tier Southampton, the Gunners now face only two competitions.In a dramatic FA Cup quarter‑final, a late goal by Shea Charles clinched a 2‑1 win for the Saints, who have been reshaped by manager Tonda Eckert from relegation candidates into promotion frontrunners within six months.Southampton opened the scoring eleven minutes before halftime when Ross Stewart capitalised on a defensive lapse, slipping a low finish past Arsenal keeper Kepa Arrizabalaga. The lead was restored shortly after when substitute Viktor Gyökeres headed home, leveling the match.However, the decisive moment arrived in the 84th minute. After a swift build‑up involving Tom Fellows, Charles received the ball inside the box and calmly placed it past the keeper, sending the Saints into the FA Cup semi‑finals at the end of the month.The victory marks only the fifth occasion this season that a team has beaten the Premier League leaders, underscoring Southampton’s resurgence. The club also honoured its 50‑year FA Cup triumph with a special yellow‑and‑blue kit, recalling Bobby Stokes' winning goal in 1976.For Arsenal, the defeat compounds recent setbacks. Manager Mikel Arteta now has less than 48 hours before the team departs for Lisbon to face Sporting CP in the Champions League quarter‑final first leg, followed by a crucial Premier League clash at Manchester City.Despite the loss, Arsenal showed flashes of life, with Gyökeres equalising and a flurry of chances in stoppage time, but Southampton’s disciplined defence and Charles’ composure proved decisive.